Dopamine D1 and D2 receptor antagonism during development alters later behavior in zebrafish

被引:12
|
作者
Oliveri, Anthony N. [1 ]
Levin, Edward D. [1 ,2 ]
机构
[1] Duke Univ, Dept Pharmacol & Canc Biol, Sch Med, Durham, NC 27710 USA
[2] Duke Univ, Dept Psychiat & Behav Sci, Sch Med, Durham, NC 27710 USA
基金
美国国家环境保护局;
关键词
Zebrafish; Dopamine; Development; Sensorimotor; Shoaling; Predatory escape; LARVAL ZEBRAFISH; EXPOSURE; HALOPERIDOL; NICOTINE; NEUROCHEMISTRY; IMPAIRMENT; EXPRESSION; PREFERENCE; ETHANOL; SYSTEMS;
D O I
10.1016/j.bbr.2018.08.028
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
This study sought to examine the long-term behavioral impacts of dopamine D-1 and D-2 receptor antagonism during development in zebrafish (Danio rerio). Zebrafish embryos of both the AB* and 5D strains were exposed via immersion to either the D(1 )receptor antagonist SCH-23,390 or the D2 receptor antagonist haloperidol, at either 0.5 or 1.5-mu M, from 5 h post-fertilization to 5 days post-fertilization. Aquarium water served as a control. Fish were then either tested as larvae on day 6 post-fertilization on a light/dark locomotor assay, or were grown to adulthood and tested on a behavioral battery that included assays for novel environment exploration, startle habituation, social affiliation, and predator escape (AB* strain only). Overall, developmental exposure to dopamine D 1 and D2 receptor antagonists caused clear effects in larval locomotor behavior, driving hyperactivity in dark phases and hypoactivity in light phases. Additionally, control fish from the two strains were significantly different from each other (p < 0.05) with the AB* fish being more active than SD during the dark periods of the test. In the adult behavioral battery, developmental exposure to 1.5-mu M of the D-1 antagonist SCH-23390 significantly reduced activity (p < 0.05) in the predator escape assay. Despite the fact that embryonic exposure to D-1 and D-2 receptor antagonists caused clear behavioral alterations in larval activity there were much more subtle effects persisting into adulthood.
引用
收藏
页码:250 / 256
页数:7
相关论文
共 50 条
  • [41] Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism
    Prabhu, Varun V.
    Madhukar, Neel S.
    Gilvary, Coryandar
    Kline, C. Leah B.
    Oster, Sophie
    El-Deiry, Wafik S.
    Elemento, Olivier
    Doherty, Faye
    VanEngelenburg, Alexander
    Durrant, Jessica
    Tarapore, Rohinton S.
    Deacon, Sean
    Charter, Neil
    Jung, Jinkyu
    Park, Deric M.
    Gilbert, Mark R.
    Rusert, Jessica
    Wechsler-Reya, Robert
    Arrillaga-Romany, Isabel
    Batchelor, Tracy T.
    Wen, Patrick Y.
    Oster, Wolfgang
    Allen, Joshua E.
    CLINICAL CANCER RESEARCH, 2019, 25 (07) : 2305 - 2313
  • [42] Pharmacological Analysis of Human D1 and D2 Dopamine Receptor Missense Variants
    Munya A. Al-Fulaij
    Yong Ren
    Martin Beinborn
    Alan S. Kopin
    Journal of Molecular Neuroscience, 2008, 34
  • [43] Wake-promoting actions of dopamine D1 and D2 receptor stimulation
    Isaac, SO
    Berridge, CW
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (01): : 386 - 394
  • [44] Structural insights into the human D1 and D2 dopamine receptor signaling complexes
    Zhuang, Youwen
    Xu, Peiyu
    Mao, Chunyou
    Wang, Lei
    Krumm, Brian
    Zhou, X. Edward
    Huang, Sijie
    Liu, Heng
    Cheng, Xi
    Huang, Xi-Ping
    Shen, Dan-Dan
    Xu, Tinghai
    Liu, Yong-Feng
    Wang, Yue
    Guo, Jia
    Jiang, Yi
    Jiang, Hualiang
    Melcher, Karsten
    Roth, Bryan L.
    Zhang, Yan
    Zhang, Cheng
    Xu, H. Eric
    CELL, 2021, 184 (04) : 931 - +
  • [45] Involvement of D1 and D2 dopamine receptor in the retrieval processes in latent inhibition
    Diaz, E.
    Medellin, J.
    Sanchez, N.
    Vargas, J. P.
    Lopez, J. C.
    PSYCHOPHARMACOLOGY, 2015, 232 (23) : 4337 - 4346
  • [46] Pharmacological analysis of human D1 and D2 dopamine receptor missense variants
    Al-Fulaij, Munya A.
    Ren, Yong
    Beinborn, Martin
    Kopin, Alan S.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2008, 34 (03) : 211 - 223
  • [47] POLYDIPSIA AND DOPAMINE - BEHAVIORAL-EFFECTS OF DOPAMINE D1 AND D2 RECEPTOR AGONISTS AND ANTAGONISTS
    MITTLEMAN, G
    ROSNER, AL
    SCHAUB, CL
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 271 (02): : 638 - 650
  • [48] First enantioselective syntheses of the dopamine D1 and D2 receptor modulators, (+)- and (-)-govadine
    Zhai, Huimin
    Miller, James
    Sammis, Glenn
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (04) : 1557 - 1559
  • [49] Adolescent Maturation of Dopamine D1 and D2 Receptor Function and Interactions in Rodents
    Dwyer, Jennifer B.
    Leslie, Frances M.
    PLOS ONE, 2016, 11 (01):
  • [50] Involvement of D1 and D2 dopamine receptor in the retrieval processes in latent inhibition
    E. Diaz
    J. Medellín
    N. Sánchez
    J. P. Vargas
    J. C. López
    Psychopharmacology, 2015, 232 : 4337 - 4346